Benitec Biopharma LtdCompany Details

Get alertedif Benitec Biopharma Ltd gets funded!
Company description

Benitec Biopharma holds the dominant global patent position for expressed RNA interference (or DNA-directed RNAi (ddRNAi)), placing it in a commanding position for therapies for human conditions associated with specific genes and genetic disorders. The use of shRNA for human use falls under our patent estate.


Funding history

Create alert
Want to know when Benitec Biopharma Ltd gets funded?
Please note that all data is automatically extracted and errors can occur.
The WhoGotFunded team has not necessarily reviewed the information in this page and has not determined if it is accurate and complete.
Inaccurate Data? Help us improve WhoGotFunded: post a comment!